Volume 90 Issue 4 | pp. 13-14 | Concentrates
Issue Date: January 23, 2012

Carbogen Buys French Finished-Dosage Firm

Department: Business
Keywords: pharmaceutical chemicals, acquisitions, finished dose drugs

Carbogen Amcis, a Swiss pharmaceutical chemical firm, has acquired Creapharm Parenterals, a division of France’s Creapharm involved in the contract manufacture of finished-dose drugs. The deal will allow Carbogen to provide customers with services “from process development to the supply of pharmaceutical substances and formulated products,” says CEO Mark Griffiths. Fine chemicals makers such as Cambrex and Albany Molecular Research Inc. also have added drug formulation capabilities to their service offerings.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment